CareRx (FRA:29C1) Cyclically Adjusted Revenue per Share: €6.31 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:29C1 CareRx Corp FRA:29C1
66 GF Score
Price €2.04
GF Value €1.37
! 3 Warning Signs
View Full Analysis

What is CareRx Cyclically Adjusted Revenue per Share?

CareRx FRA:29C1 66 Cyclically Adjusted Revenue per Share is €6.31 as of Jun. 2026. GuruFocus rates FRA:29C1 with a GF Score™ of 66/100 and a GF Value™ of €1.37. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CareRx's adjusted revenue per share for the three months ended in Jun. 2026 was €0.889. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €6.31 for the trailing ten years ended in Jun. 2026.

During the past 12 months, CareRx's average Cyclically Adjusted Revenue Growth Rate was -14.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -13.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -15.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of CareRx was 7.00% per year. The lowest was -17.60% per year. And the median was -0.50% per year.

As of today (2026-08-09), CareRx's current stock price is €2.04. CareRx's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €6.31. CareRx's Cyclically Adjusted PS Ratio of today is 0.32.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CareRx was 0.67. The lowest was 0.08. And the median was 0.20.


CareRx  (FRA:29C1) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CareRx's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.04/6.31
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CareRx was 0.67. The lowest was 0.08. And the median was 0.20.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CareRx Cyclically Adjusted Revenue per Share Related Terms


CareRx Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for CareRx's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CareRx Cyclically Adjusted Revenue per Share Chart

CareRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,981.58 8,477.56 8.83 8.47 6.91

CareRx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.76 6.89 6.91 6.71 6.31

FRA:29C1 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, CareRx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareRx Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareRx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CareRx's Cyclically Adjusted PS Ratio falls into.


FRA:29C1
66GF Score
CareRx Corp FRA:29C1
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CareRx Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CareRx's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.889/133.5265*133.5265
=0.889

Current CPI (Jun. 2026) = 133.5265.

CareRx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 3.479 101.765 4.565
201612 3.514 101.449 4.625
201703 3.386 102.634 4.405
201706 2.875 103.029 3.726
201709 2.748 103.345 3.551
201712 -0.283 103.345 -0.366
201803 2.043 105.004 2.598
201806 1.895 105.557 2.397
201809 1.801 105.636 2.277
201812 1.905 105.399 2.413
201903 1.855 106.979 2.315
201906 1.983 107.690 2.459
201909 2.026 107.611 2.514
201912 1.809 107.769 2.241
202003 0.797 107.927 0.986
202006 1.388 108.401 1.710
202009 1.265 108.164 1.562
202012 -0.093 108.559 -0.114
202103 1.069 110.298 1.294
202106 1.111 111.720 1.328
202109 1.326 112.905 1.568
202112 1.492 113.774 1.751
202203 1.437 117.646 1.631
202206 1.520 120.806 1.680
202209 1.553 120.648 1.719
202212 1.329 120.964 1.467
202303 1.128 122.702 1.228
202306 1.039 124.203 1.117
202309 1.125 125.230 1.200
202312 1.062 125.072 1.134
202403 1.019 126.258 1.078
202406 1.037 127.522 1.086
202409 1.028 127.285 1.078
202412 1.014 127.364 1.063
202503 0.898 129.181 0.928
202506 0.892 129.892 0.917
202509 0.884 130.287 0.906
202512 0.928 130.366 0.950
202603 0.916 132.262 0.925
202606 0.889 133.527 0.889

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €6.31 mean?
CareRx (FRA:29C1) has a Cyclically Adjusted Revenue per Share of €6.31 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CareRx and its competitors.
Is CareRx's Cyclically Adjusted Revenue per Share too high?
CareRx's current Cyclically Adjusted Revenue per Share is €6.31. Overall, CareRx has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does CareRx's Cyclically Adjusted Revenue per Share compare to HCA and THC?
CareRx's Cyclically Adjusted Revenue per Share of €6.31 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CareRx and its competitors. CareRx's current Cyclically Adjusted Revenue per Share is €6.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareRx stock overvalued right now?
CareRx (FRA:29C1) has a current Cyclically Adjusted Revenue per Share of €6.31. The stock's GF Value™ is €1.37, compared to a current price of €2.04 — trading 48.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €6.31. CareRx's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For CareRx (FRA:29C1), the current Cyclically Adjusted Revenue per Share is €6.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CareRx (FRA:29C1) Overvalued in 2026?

Based on GuruFocus' analysis, CareRx stock appears to be overvalued. The current stock price of €2.04 is trading 48.9% above its estimated GF Value™ of €1.37.

Key valuation signals for FRA:29C1:

  • Cyclically Adjusted Revenue per Share: €6.31
  • GF Value™: €1.37 vs. price of €2.04 (48.9% above fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the FRA:29C1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CareRx Business Description

Other Exchanges CHHHF:USACRRX:Canada
Address 320 Bay Street, Suite 1200, Toronto, ON, CAN, M5H 4A6
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
66GF Score

Get the complete analysis for FRA:29C1

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.04
Price
€1.37
GF Value